Insulin Antibodies (IAA)
Also called IAA
Autoantibodies against insulin — either against your own insulin (autoimmune) or against previously injected insulin.
- Lab price$60.00
- RetestPer endocrinologist
What your result means
Helps identify autoimmune (type 1 / LADA) diabetes in adults who are misdiagnosed as type 2 — a genuinely consequential distinction, since the treatment differs completely.
- Standard
- Negative
- Optimal
- Negative.
- Standard
- Negative
- Optimal
- Negative.
Positive / negativeThe result is a category, not a level to optimize.
Order it yourself
One test, drawn at a Quest lab near you. The price is the lab’s, from Marek’s own menu.
Code CAMERON takes 10% off. Marek’s checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.
Order it with C-Peptide, Serum and HbA1c (Hemoglobin A1c) (3 tests, one cart)
What moves Insulin Antibodies (IAA)
Autoimmune diabetes (type 1 or latent autoimmune diabetes in adults), or prior exogenous insulin exposure.
If it’s high: Positive antibodies in an adult diagnosed with 'type 2' diabetes who is lean and responding poorly to oral medications suggests LADA — needs endocrinology, because insulin is required.
If it’s low: Normal.

The free Before‑You‑Stack Lab Kit
The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.
After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.
Everything else about Insulin Antibodies (IAA)
What your Insulin Antibodies (IAA) result means
Each possible result, and what to do next
What did your insulin antibody result show?
- Negative
- No detectable autoimmune reaction against insulin. In someone with high glucose this points toward type 2 rather than type 1 or LADA.
- Positive
- Suggests an autoimmune process against insulin or insulin-producing cells. In an adult with new hyperglycemia this raises the possibility of LADA — latent autoimmune diabetes in adults — which is frequently misdiagnosed as type 2 for years. It can also reflect antibodies formed against injected insulin.
What to do next. The distinction matters enormously for treatment: LADA misdiagnosed as type 2 gets oral agents that will progressively fail, while the beta cells are lost. GAD65 antibodies and C-peptide together give the clearer picture. This is an endocrinology conversation, and metformin or berberine are not the answer if the pancreas is being destroyed.
What can skew the result
2 things can change the reading or the real level
Some change your real level; others only change the reading. Each one says which, and what to do about it.
- Recent insulin exposureAssay
Antibodies form in response to exogenous insulin, so a positive result in someone treated with insulin is expected rather than diagnostic.
Do this: Interpret only alongside treatment history.
The number is wrong — repeat it- Interference with insulin and C-peptide assaysAssay
The antibodies themselves distort insulin measurement, sometimes producing wildly high or low readings.
Do this: A bizarre insulin result in someone with antibodies is usually the antibodies.
The number is wrong — repeat it
Plan of attack
What to do, in this order
- Confirm the number is real
Recent insulin exposure. Antibodies form in response to exogenous insulin, so a positive result in someone treated with insulin is expected rather than diagnostic. Interpret only alongside treatment history.
- Read it with its partner
Order with C-peptide — low C-peptide plus positive antibodies is the LADA picture. Draw it alongside: C-Peptide, Serum, HbA1c (Hemoglobin A1c), Fasting Insulin.
- Work out which direction is yours
If it's high — Positive antibodies in an adult diagnosed with 'type 2' diabetes who is lean and responding poorly to oral medications suggests LADA — needs endocrinology, because insulin is required.
If it's low — Normal. - Fix it in order: food, then cause, then everything else
Nutrition. Not preventable by diet once autoimmunity is established.
Lifestyle. Not modifiable. - Retest
Per endocrinologist. Change one thing at a time, or the retest can't tell you which thing worked.
Where the optimal range comes from
Not a range — a result category
Not a range — a result category. Positive or negative, a titre, a genotype. The useful content is what each answer means and what to do next.
- Measured in
- Not applicable.
- Anchored to
- Categorical. Used to investigate unexplained hypoglycemia, unexpected insulin resistance in someone on insulin, and to separate autoimmune from other causes.
- Source
- Interpretation is categorical; see the result-category block on this page.
The interference point matters more than the antibody itself: insulin antibodies distort insulin and C-peptide immunoassays, so a strange insulin result in someone who has ever used exogenous insulin should raise this possibility before it raises a metabolic conclusion. There is no optimal titre — the result is present or absent, and the follow-up is clinical.
What Insulin Antibodies (IAA) measures
And why people check it
What it tells you
Autoantibodies against insulin — either against your own insulin (autoimmune) or against previously injected insulin.
Why people check it
Helps identify autoimmune (type 1 / LADA) diabetes in adults who are misdiagnosed as type 2 — a genuinely consequential distinction, since the treatment differs completely.
What Insulin Antibodies (IAA) means next to other markers
1 pattern worth knowing
- Wildly inconsistent insulin results
Insulin antibodies positive · insulin and C-peptide implausible
Insulin antibodies distort the insulin assay itself, sometimes producing extreme high or low readings that do not fit the clinical picture at all. They form in response to exogenous insulin, so a positive result in someone treated with insulin is expected rather than a finding.
A bizarre insulin result in someone with antibodies is usually the antibodies. Interpret only alongside treatment history and C-peptide.
Panels that carry Insulin Antibodies (IAA)
3 panels, prices with code CAMERON
Read it alongside
Related markers, goals and what moves it in the library
The deep read, with sources
What the Insulin Antibodies (IAA) test actually measures, and the references
What Insulin Antibodies (IAA) actually measures — the analyte, and the assay
The analyte is an antibody, not a hormone, and two clinically different antibodies share the name. Insulin autoantibodies (IAA) arise against your own insulin and are one of the islet autoantibodies that mark type 1 diabetes and LADA. Insulin antibodies in someone who has been injected with insulin are an expected immune response to a therapeutic protein. The assay cannot distinguish them; only the exposure history can.
Measurement is by radiobinding assay — the format the international standardization workshops are built around — or by ELISA and bridging formats. Results come back as an index or titre against a cut-off, not as a concentration, because there is no way to express ‘how much antibody’ that travels between formats.
The part that matters more than the result itself: these antibodies wreck the other tests on the same panel. Insulin-antibody complexes interfere with insulin immunoassays, and they do not interfere with all of them equally — a single patient's sample run on three insulin immunoassays produced varying degrees of interference and a discordance between insulin and C-peptide that was itself the diagnostic clue Teoli 2024. The usual escape hatch is to trust C-peptide instead, and even that is not safe: in insulin autoimmune syndrome, increased C-peptide immunoreactivity has been traced to a high-molecular-weight proinsulin species rather than to real C-peptide Kay 2021. This is macro-analyte interference, the same class of problem as macroprolactin Ghazal 2022.
Insulin Antibodies (IAA): what changes the blood, and what only changes the reading
What changes the antibody in your blood:
- Exogenous insulin exposure, ever. This explains most positive results in anyone treated with insulin, and it is not a finding — it is a consequence.
- Onset of autoimmune diabetes. IAA is one of the earliest autoantibodies to appear in childhood type 1 diabetes, and one of the less sensitive ones in adults, where GAD-65 usually leads.
- Thiol-containing drugs. Insulin autoimmune syndrome (Hirata disease) is classically triggered by drugs carrying a sulfhydryl group — methimazole, alpha-lipoic acid, captopril, hydralazine — and the systematic review of published cases is where that pattern is documented Lin 2023. This is the single most actionable fact on this page: a spontaneous hypoglycemia in someone taking alpha-lipoic acid has a specific explanation.
- Genetic susceptibility, with a strong HLA class II association reported in the East Asian series that define the syndrome Lin 2023.
What changes only the reading — and the readings around it:
- Assay format. IAA is among the harder autoantibodies to standardize; a ‘weak positive’ in one format need not reproduce in another Galván 2023.
- The antibody's own interference with the insulin assay — the effect that produces an implausibly high insulin beside a normal C-peptide and sends people toward an insulinoma work-up they do not need Teoli 2024.
- Interference with C-peptide via high-molecular-weight proinsulin Kay 2021.
- Heterophile antibodies and biotin, which sit on top of all of the above Ghazal 2022.
The confirmatory maneuvers are laboratory ones, not clinical: polyethylene glycol precipitation and gel-filtration chromatography, which separate free hormone from antibody-bound complexes and reveal how much of the reported signal was never free insulin Galván 2023 Kay 2021.
Reference interval or decision threshold — which kind of number Insulin Antibodies (IAA) is
Neither — it is a category, and the boundary of the category is a statistical decision rather than a biological one.
Autoantibody cut-offs are conventionally set at a high percentile of a non-diabetic reference population, most often the 99th. That has a consequence people rarely state: at the 99th percentile, roughly 1 in 100 people without disease will be called positive by construction. A ‘weak positive’ is therefore a statement about where you sit in a reference distribution, not a statement that you have an autoimmune process.
The number that behaves like a genuine decision threshold in this area is not the antibody at all — it is the combination the antibody feeds into: C-peptide with a simultaneous glucose, read against the clinical picture Galván 2023. Interpretation is categorical, which is why this page's result box is a category rather than a range.
How you would know your Insulin Antibodies (IAA) was wrong — and when to redraw
An IgG response turns over in weeks, so a repeat inside a month is wasted. Immunoglobulin G has a circulating half-life around 21 days, and a titre reflects an ongoing B-cell response rather than a pool that washes out, so meaningful change is a matter of months. Where a drug trigger is removed in insulin autoimmune syndrome, resolution over months is the documented course Lin 2023.
What would have to change for a second value to mean anything. The antibody is never the decision. Redraw it with a simultaneous C-peptide and glucose from the same tube, and with HbA1c and fasting insulin — because the question this test is actually being asked (is this autoimmune diabetes or type 2?) is answered by that combination, and by GAD-65, not by a titre.
And if insulin and C-peptide are wildly discordant, the next step is not a repeat. It is a PEG precipitation on the existing sample, because the hypothesis is that the assay is being fooled, and repeating the same assay will fool it identically Teoli 2024 Galván 2023.
What Insulin Antibodies (IAA) cannot tell you
It cannot separate autoimmunity from exposure in anyone who has ever been given insulin. In that population a positive result is expected and uninformative.
It cannot diagnose LADA on its own. GAD-65 is the more sensitive antibody in adults; a negative IAA does not exclude autoimmune diabetes, and a positive one does not establish it without the clinical and C-peptide picture.
It cannot tell you whether your insulin result is real. That is the inversion worth holding onto: the antibody is often ordered to explain a strange insulin, but a negative antibody does not certify the insulin number, because heterophile and macro-analyte interference produce the same picture by other routes Ghazal 2022.
The wrong inference readers draw is that a positive insulin antibody means insulin resistance or ‘insulin allergy’. In a non-diabetic with spontaneous hypoglycemia it means something far more specific — and far more treatable, because the trigger is often a supplement or a drug that can simply be stopped Lin 2023.
Sources read for these sections
- Teoli J, et al. When discordant insulin and C-peptide levels lead to a medical diagnosis in a patient with transient hypoglycemia: Varying degrees of interference of insulin-antibody complexes on three insulin immunoassays. Heliyon 2024 · PMID 39071705
- Kay RG, et al. Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin. Clinical Chemistry 2021 · PMID 34051096
- Lin M, et al. Insulin Autoimmune Syndrome: A Systematic Review. International Journal of Endocrinology 2023 · PMID 36844104
- Galván R, et al. Complete laboratory diagnosis of Insulin Autoimmune Syndrome. Practical Laboratory Medicine 2023 · PMID 37649545
- Ghazal K, et al. Hormone Immunoassay Interference: A 2021 Update. Annals of Laboratory Medicine 2022 · PMID 34374345
Insulin Antibodies (IAA) questions
5 answered
- What is a normal Insulin Antibodies (IAA) level?
- Women: Negative. Men: Negative. Ranges vary by laboratory and assay; always compare to the range printed on your own report.
- What is the optimal Insulin Antibodies (IAA) level?
- Women: Negative. Men: Negative. Interpretation is categorical; see the result-category block on this page.
- What does an abnormal Insulin Antibodies (IAA) result mean?
- Positive antibodies in an adult diagnosed with 'type 2' diabetes who is lean and responding poorly to oral medications suggests LADA — needs endocrinology, because insulin is required.
- How often should I retest Insulin Antibodies (IAA)?
- Per endocrinologist.
- How do I test Insulin Antibodies (IAA)?
- Through Marek Diagnostics without a doctor's visit, drawn at a Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically through the links on this page.
Sources: American Diabetes Association Standards of Care — diabetes classification and autoantibody testing.
The Metabolic Health & Prediabetes protocol is a lesson in Skool
This page tells you what the number means and the order to act in. Skool is where it becomes a plan for your situation, read against your own labs.
- The full Metabolic Health & Prediabetes protocol, step by step
- Supplement form, timing and how long to run it
- The hormones and compounds that move it, and what to watch
5.0 (15 reviews)1,500+ members

Want it built around you?
Educational and research purposes only. Not medical advice; talk to your clinician about results. Lab ranges vary by assay and laboratory: compare against the range printed on your own report. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer and affiliate disclosure